(Q45718660)

English

Nitric oxide synthase 2 is required for conversion of pro-fibrogenic inflammatory CD133(+) progenitors into F4/80(+) macrophages in experimental autoimmune myocarditis

scientific article published on 22 October 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 December 2017

Nitric oxide synthase 2 is required for conversion of pro-fibrogenic inflammatory CD133(+) progenitors into F4/80(+) macrophages in experimental autoimmune myocarditis (English)

1 reference

Europe PubMed Central

15 December 2017

Thomas Lüscher

7

object named as

Thomas F Lüscher

1 reference

Europe PubMed Central

15 December 2017

object named as

Urs Eriksson

8

0 references

Przemysław Błyszczuk

1

object named as

Przemyslaw Blyszczuk

1 reference

Europe PubMed Central

15 December 2017

9

object named as

Gabriela Kania

1 reference

Europe PubMed Central

15 December 2017

author name string

Corrine Berthonneche

2

1 reference

Europe PubMed Central

15 December 2017

Silvia Behnke

3

1 reference

Europe PubMed Central

15 December 2017

Marcel Glönkler

4

1 reference

Europe PubMed Central

15 December 2017

Holger Moch

5

1 reference

Europe PubMed Central

15 December 2017

Thierry Pedrazzini

6

1 reference

Europe PubMed Central

15 December 2017

publication date

22 October 2012

1 reference

Europe PubMed Central

15 December 2017

Cardiovascular Research

1 reference

Europe PubMed Central

15 December 2017

97

1 reference

Europe PubMed Central

15 December 2017

2

1 reference

Europe PubMed Central

15 December 2017

219-229

1 reference

Europe PubMed Central

15 December 2017

Autoimmune myocarditis: past, present and future

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS317

21 January 2018

Myocarditis: infection versus autoimmunity

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS317

21 January 2018

Mechanisms of cardiac fibrosis in inflammatory heart disease.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS317

21 January 2018

Heart-infiltrating prominin-1+/CD133+ progenitor cells represent the cellular source of transforming growth factor beta-mediated cardiac fibrosis in experimental autoimmune myocarditis.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS317

21 January 2018

Alternatively activated macrophages in infection and autoimmunity

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS317

21 January 2018

Alternative activation of macrophages: mechanism and functions

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS317

21 January 2018

Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS317

21 January 2018

Hematopoietic colony stimulating factors in cardiovascular and pulmonary remodeling: promoters or inhibitors?

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS317

21 January 2018

Colony-stimulating factors in inflammation and autoimmunity.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS317

21 January 2018

Bone marrow-derived CXCR4+ cells mobilized by macrophage colony-stimulating factor participate in the reduction of infarct area and improvement of cardiac remodeling after myocardial infarction in mice

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS317

21 January 2018

Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS317

21 January 2018

Granulocyte colony stimulating factor/macrophage colony stimulating factor improves postinfarct ventricular function by suppression of border zone remodelling in rats.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS317

21 January 2018

Macrophage colony-stimulating factor improves cardiac function after ischemic injury by inducing vascular endothelial growth factor production and survival of cardiomyocytes

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS317

21 January 2018

Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS317

21 January 2018

Nitric oxide inhibits viral replication in murine myocarditis

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS317

21 January 2018

The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS317

21 January 2018

Nitric oxide and redox mechanisms in the immune response

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS317

21 January 2018

Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS317

21 January 2018

Identifiers

10.1093/CVR/CVS317

1 reference

Europe PubMed Central

15 December 2017

1 reference

Europe PubMed Central

15 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45718660&oldid=2107799353"